This week's Java roundup for January 26th, 2026, features news highlighting: an update on milestone and GA release schedule ...

Novo Nordisk A/S is rated a buy, driven by FDA approval of its oral Wegovy, strong fundamentals, and attractive valuation versus Eli Lilly. Recent clinical data and first-mover advantage position ...

Good morning, everybody. I'm Chris Schott from JPMorgan, and it's my pleasure to be introducing Teva today. From the company, we have CEO, Richard Francis. Richard has been at Teva for roughly 3 years ...

The U.S. Food and Drug Administration says it will ease regulatory requirements for certain consumer wearable health devices. Officials say the move is intended to speed innovation while maintaining ...

News-driven FX Trading: How to Trade Events Like the FOMC, CPI, and NFP XRP rebounds above $3.01, leading crypto top ten as traders eye pivotal October SEC ETF decisions. SEC delays XRP-spot ETF ...